The use of dermatological cosmetic preparations for the combined treatment of atopic dermatitis in the children

Smirnova G.I.

doi:https://doi.org/

Smirnova G.I.

Pervyĭ moskovskiĭ gosudarstvennyĭ meditsinskiĭ universitet im. I.M. Sechenova

The use of dermatological cosmetic preparations for the combined treatment of atopic dermatitis in the children

Authors:

Smirnova G.I.

More about the authors

Journal: Russian Journal of Clinical Dermatology and Venereology. 2012;10(3): 99‑105

Read: 1710 times

Download PDF (RU)

Contact the author

Table of contents

To cite this article:

Smirnova GI. The use of dermatological cosmetic preparations for the combined treatment of atopic dermatitis in the children. Russian Journal of Clinical Dermatology and Venereology. 2012;10(3):99‑105. (In Russ.)

Подписка 2026 Клиническая дерматология и венерология (Russian Journal of Clinical Dermatology and Venereology)

Использование инфографики авторами научных работ

References:

Smirnova G.I. Allergodermatozy u detei. M 1998; 300.
Smirnova G.I. Sovremennaya kontseptsiya lecheniya atopicheskogo dermatita. M 2006; 132.
Scheinmann P., Pham Thi N., Karila C. et al. Allergic march in children, from rhinitis to asthma: management, indication of immunotherapy. Arch Pediat 2012; 19: 330-334.
Bussmann C., Weidinger S., Novak N. Genetics of atopic dermatitis. J Dtsch Dermatol Ges 2011; 9: 670-676.
McGrath J.A. Profilaggrin, dry skin, and atopic dermatitis risk: size matters. J Invest Dermatol 2012; 132: 10-11.
Boguniewicz M., Leung D.Y. Atopic dermatitis: a disease of altered skin barrier and immune dysregulation. Immunol Rev 2011; 242: 233-246.
Heimall J., Spergel J.M. Filaggrin mutations and atopy: consequences for future therapeutics. Exp Rev Clin Immunol 2012; 8: 189-197.
Wang I.J., Lin T.J., Kuo C.F. et al. Filaggrin polymorphism P478S, IgE level, and atopic phenotypes. Br J Dermatol 2011; 164: 791-796.
Osawa R., Akiyama M., Shimizu H. Filaggrin gene defects and the risk of developing allergic disorders. Allergol Int 2011; 60: 1-9.
Novak N., Simon D. Atopic dermatitis - from new pathophysiologic insights to individualized therapy. Allergy 2011; 66: 830-839.
Wichmann K., Heratizadeh A., Werfel T. Food allergy in atopic dermatitis. Hautarzt 2012; 63: 315-324.
Miajlovic H., Fallon P.G., Irvine A.D. et al. Effect of filaggrin breakdown products on growth of and protein expression by Staphylococcus aureus. J Allergy Clin Immunol 2010; 126: 1184-1190.
Grant J.A. Molecular pharmacology of second-generation antihistamines. Allergy Asthma Proc 2000; 21: 135-140.
Yeşilova Y., çalka Ö., Akdeniz N. et al. Effect of probiotics on the treatment of children with atopic dermatitis. Ann Dermatol 2012; 24: 189-193.
Simon D. Systemic therapy of atopic dermatitis in children and adults. Curr Probl Dermatol 2011; 41: 156-164.
Kircik L.H., Del Rosso J.Q. Nonsteroidal treatment of atopic dermatitis in pediatric patients with a ceramide-dominant topical emulsion formulated with an optimized ratio of physiological lipids. J Clin Aesthet Dermatol 2011; 4: 25-31.
Hebert A.A. Review of pimecrolimus cream 1% for the treatment of mild to moderate atopic dermatitis. Clin Ther 2006; 28: 1972-1982.
Smirnova G.I. Emol'yanty v naruzhnoi terapii atopicheskogo dermatita u detei. Ros pediat zhurn 2011; 4: 37-42.
Wellington K., Jarvis B. Topical pimecrolimus: a review of its clinical potential in the management of atopic dermatitis. Drugs 2002; 62: 817-840.
Simpson E., Dutronc Y. A new body moisturizer increases skin hydration and improves atopic dermatitis symptoms among children and adults. J Drugs Dermatol 2011; 10: 744-749.